Press ReleaseThe 136th Canton Fair Advances High-Quality Development of International Trade with Overseas Buyers Attendance Hitting Record Numbers GUANGZHOU, China, Nov. 6, 2024 /PRNewswire/ — The 136th Canton Fair has… CISION PRNewswireNovember 6, 2024
CNOOC Limited Brings On-stream Long Lake NW Project in Canada HONG KONG, Nov. 6, 2024 /PRNewswire/ — CNOOC Limited (the "Company", SEHK:… CISION PRNewswireNovember 6, 2024
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 6, 2024
Press ReleaseThailand announces 2025 as the "Amazing Thailand Grand Tourism and Sports Year" At WTM 2024, Thailand’s Tourism and Sports Minister reveals 2025 tourism agenda… CISION PRNewswireNovember 6, 2024
Press ReleaseGTI Initiates Global Recruitment for Intelligent RAN, Ubiquitous AI Project of 5G-A×AI Development Program ISTANBUL, Nov. 6, 2024 /PRNewswire/ — At the Global MBB Forum 2024 (MBBF… CISION PRNewswireNovember 6, 2024
Press ReleaseVolta Energy Solutions Hungary pursues 'The Copper Mark' award The "Copper Mark" is the leading assurance framework to promote responsible practices… CISION PRNewswireNovember 6, 2024
ATRenew to Report Third Quarter 2024 Financial Results on November 20, 2024 SHANGHAI, Nov. 6, 2024 /PRNewswire/ — ATRenew Inc. ("ATRenew" or the "Company")… CISION PRNewswireNovember 6, 2024
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma… CISION PRNewswireNovember 6, 2024
